Lonza : Price Change Notification on Selected Product Portfolios
May 07, 2021 at 02:03 am
Share
Basel, Switzerland, 07 May, 2021 - Effective 10 May, 2021 or as dictated by the terms of individual contracts, Lonza Specialty Ingredients (LSI) will implement list and off-list price adjustments for selected products globally.
The selected price increases are a result of the prevailing supply market conditions and the related increase in raw material, equipment, logistics, and supply chain costs.
LSI reaffirms its commitment to the reliable supply of products, service and value to its customers. If you have any questions regarding this price increase, please do not hesitate to contact your local sales representative or account manager.
Attachments
Original document
Permalink
Disclaimer
Lonza Group Ltd. published this content on 07 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 May 2021 06:02:00 UTC.
Lonza Group AG is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows:
- bio-pharmaceuticals (52.6%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, etc.;
- capsules and dosing solutions for biopharmaceuticals, drugs and nutrition products (20.3%). In addition, the group offers nutritional ingredients;
- small molecule drug substances (13.2%);
- technologies and platforms for manufacturing processes and production of cell and gene therapies (11.1%);
- other (2.8%).
Net sales are distributed geographically as follows: Switzerland (16%), Europe (29.8%), the United States (38.8%), the Americas (3%), Japan (3.7%), China (2.6%), Asia (5.8%) and other (0.3%).